Himawan Jeff

Avg. Two Year Performance

156% Avg. Purchase Return
60% Compound
(19%) Avg. Sale Return
(9%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return10%9%< 1%(45%)156%
Purchase Success Rate3 of 54 of 52 of 50 of 51 of 5
Average Sale Return(19%)(45%)(84%)(14%)(19%)
Sale Success Rate0 of 20 of 20 of 21 of 21 of 2

Targacept, Inc.

Drugs » Biotechnology

Director, 10% Owner:

Holdings: 3.39M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

MediciNova Inc.

Drugs » Biotechnology

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Intercell Usa, Inc.

Drugs » Biotechnology

Director:

Holdings: 2.8M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Horizon Pharma, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--